서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 30 of 59

Issue DateTitle / Author(s) / CitationFileAltmetrics
2023-02
Quantification of venadaparib, a novel PARP inhibitor, in the rat and dog plasma using liquid chromatography/tandem mass spectrometry
view fileDOI
2022-10
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
DOI
2021-09
The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study

Jang, Young-Eun; Ji, Sang-Hwan; Lee, Ji-Hyun; Kim, Eun-Hee; Kim, Jin-Tae; Kim, Hee-Soo

BMC Anesthesiology. 2021 Sep 09;21(1):222

view fileDOI
2021-09
The relationship between the effect-site concentration of propofol and sedation scale in children: a pharmacodynamic modeling study
DOI
2021-07
Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems

Kwon, Seungbin; Kim, Kyung Bo; Yeo, Yoon; Lee, Wooin

Journal of Pharmaceutical Investigation, Vol.51 No.4, pp.483-502

DOI
2021-05
Impact of a computerised clinical decision support system on vancomycin loading and the risk of nephrotoxicity
DOI
2021-02
Estimation of number of liver subcompartments to predict hepatic availability from in vitro data in rats
link
2021-02
Impacts of drug interactions on pharmacokinetics and the brain transporters: A recent review of natural compound-drug interactions in brain disorders

Khadka, Bikram; Lee, Jae-Young; Park, Eui Kyun; Kim, Ki-Taek; Bae, Jong-Sup

International Journal of Molecular Sciences, Vol.22 No.4, pp.1-20

DOI
2020-11
Preparation and characterization of sorafenib-loaded microprecipitated bulk powder for enhancing oral bioavailability

Park, Ju-Hwan; Baek, Min-Jun; Lee, Jae-Young; Kim, Ki-Taek; Cho, Hyun-Jong; Kim, Dae-Duk

International Journal of Pharmaceutics, Vol.589, p. 119836

DOI
2020-06
Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study
DOI
2020-03
Development of an oral bentonite-based modified-release freeze-dried powder of vactosertib: Pharmacokinetics and anti-colitis activity in rodent models of ulcerative colitis
DOI
2020
Development of Micelle-encapsulated ESIONs as a T1 Contrast Imaging Agent : Prolonged Blood Circulation and Enhanced Hepatobiliary Excretion
view filelink
2020
Comparison of Conventional Blood Sampling and Sampling by Volumetric Absorptive Microsampling (VAMS) Device for Pharmacokinetic Analysis
view filelink
2018-07
Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)
view fileDOI
2017-08
Determination and validation of LJ-2698, a potent human A(3) adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study
DOI
2017-02
Study on Factors Limiting Intestinal Drug Absorption: Contribution of interplay between metabolism and efflux transport in intestinal epithelial cells, and intestinal stability on the absorption
view file
2017-02
Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for an rOATP1B2-Mediated Interaction in Hepatic Transport
view file
2017-02
Human pharmacokinetic profiles of propyl paraben after oral administration
view file
2016-10
Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs
DOI
2016-04
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies
DOI
2016-02
A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMET™ Plus platform
view file
2016-02
Determination of manassantin B in rat plasma using a high performance liquid chromatography with fluorescence detection and its quantitative application to pharmacokinetic study

Lee, Jae-Young; Song, Jae-Hyoung; Yoon, In-Soo; Ko, Hyun-Jeong; Kim, Dae-Duk; Cho, Hyun-Jong

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol.1011, pp.121-127

DOI
2015-12
Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia
DOI
2015-10
Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer
DOI
2015-09
Determination and validation of psammaplin A and its derivatives in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study

Lee, Jae-Young; Lee, Mee Yeon; Ha, Min Woo; Won, Tae Hyung; Cho, Hyun-Jong; Shin, Jongheon; Park, Hyeung-geun; Kim, Dae-Duk

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol.1000, pp.155-162

DOI
2015-02
Kinetics of the Absorption, Distribution, Metabolism and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-activated Receptor Gamma in Rats
view file
2015-02
Aspirin decreases the systemic exposure to clopidogrel through modulation of P-glycoprotein, but does not alter its antithrombotic activity
view file
2014-07
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer
DOI
2014-03
Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug
view fileDOI
2014-02
A Bayesian Approach to Robust Parameter Estimation of Physiologically Based Pharmacokinetics Model with Drug Dissolution Model
view file
1 2